Use of Genes as Molecular Markers in the Diagnosis of Schizophrenia and Diagnostic Kit for the Same
The offered technology developed by a Hungarian Research Institute provides a new method for diagnosing schizophrenia. The technology can be used for the development of a diagnostic kit for schizophrenia. Currently schizophrenia is diagnosed on the basis of symptom examination which has several disadvantages. The invention shifts the diagnosis of schizophrenia from the subjective field of symptom interpretation to the more exact quantification of gene expression. There is an abundance of data evidencing that there is a genetic linkage of schizophrenia and that the expression pattern of certain genes is altered in patients with schizophrenia. Genetic marker-based diagnosis of psychiatric disorders would be more accurate and rapid than currently used, symptom-based diagnosis. Early diagnosis and treatment of schizophrenia may have a significant impact, because more optimal management at an early stage of the illness may alter its course. Our results identify 2 genes with a changed expression in schizophrenic patients. Measurements are done on the blood of a patient.
Sector: Medical Technologies
Area of Application: Medical Technologies: Potential purchasers of the kit are medical institutions, including especially psychiatric departments of hospitals, psychiatrists and private psychiatric clinics.
Keywords: schizophrenia, diagnosis, therapeutics, health
Advantages: The invention allows for faster, exacter and easier diagnosis.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent
Transfer Terms: Joint Venture , Technology Licensing , Others
Estimated cost (US$):
Upload any relevant document:
Contact Person: Laser Consult Ltd (Hungary)
Address: H-6701 PO Box 1191.